Top compounds associated with response to TAS2R20


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA CIL41 CTRPv2 pan-cancer AAC 0.066 0.2
mRNA paclitaxel gCSI pan-cancer AAC -0.066 0.2
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.063 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.2
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.049 0.2
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA A-804598 CTRPv2 pan-cancer AAC 0.057 0.2
Download CSV